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ABSTRACT
ALEX OLIVERI, ANSHUL ANUGU, SHADE SMITH: Diagnostic Approaches to Combat Antibiotic Resistance in
Bacteria
(Under the direction of Dr. Colin Jackson)

The threat of antibiotic resistance is a major problem faced by the healthcare field affecting millions
of people and costing tens of thousands of lives annually. Of the potential ways to mitigate this issue the field
of antibiotic resistance testing presents an opportunity for significant improvement and benefits. Several
methods of such diagnostic processes can yield more informative results than the current commonly used
Kirby-Bauer test. However, there are benefits and limitations to each method. In the context of a clinically
relevant diagnostic for antibiotic resistance, the microarray platform exhibits the necessary breadth with
opportunities to overcome some limitations with further research and development. There is potential for
innovation of this method to automate it and optimize its efficiency in a clinical setting for the purpose of
antibiotic resistance diagnosis. This presents a hopeful tool that physicians can rely upon to combat antibiotic
resistance and improve patient outcomes.
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INTRODUCTION

The problem of antibiotic resistance is a major concern to global healthcare. There is a large and
rapid emergence of antibiotic resistant bacteria occurring worldwide, threatening the efficacy of current
antibiotics. This problem has created a substantial burden on hospitals, health care systems, insurance
companies, families, and government. The CDC classifies this as an urgent issue and as one of the biggest
public health challenges of our time, as each year, at least 2.8 million people in the United States contract an
antibiotic resistant infection, which accounts for more than 35,000 deaths [1].
The emergence of this antibiotic resistance crisis can be traced to the abundant use of
antibiotics [1]. National guidelines have been created to assist with proper stewardship of
antibiotics, and many education programs are in place. However, the extent to which antibiotics
are prescribed improperly is not well known. Data from 182,032 outpatient visits from 20102011 suggest that an estimated 154 million prescriptions are prescribed annually, or 506 per
1000 people [2]. Of those 506 instances of antibiotic prescription, experts on outpatient antibiotic
use suggest that only 353 were likely appropriate [2].
Since that study, the CDC reports that education programs are working, and antibiotic use
has been reduced [1]. However, antibiotics are still used in massive quantities and stewardship is
still an issue. Regarding decreasing antibiotic use for common infections, there seems to be a
balancing act. There is concern of doctors about issues such as suppurative complications and the
desire of patients to prioritize their individual health that drives antibiotic prescription up [2].
Indeed, patients are less satisfied when not prescribed antibiotics [3]. In contrast, national and
international antibiotic stewardship programs and governmental guidelines seek to drive
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prescriptions down. However, even with appropriate antibiotic use, there would still be 107
million prescriptions annually in the United States alone [2]. This prolific use of antibiotics
drives further resistance.
The COVID epidemic of 2019-2021 could also have a potential impact on antibiotic
resistance, potentially through increased telehealth visits. Antibiotic stewardship practices are
worse for telehealth: For example, for acute respiratory tract infections, 52% of telemedicine
encounters resulted in antibiotic prescription as opposed to 31% of primary care and 42% of
urgent care visits [4]. This is a supposed result of the lack of diagnostic procedures such as
physical exams and laboratory tests [4].
Another study of 8,437 respiratory tract infection telemedicine encounters found that
there is a significant correlation between physician rating and antibiotic prescription rate.
Further, 66.1% of encounters resulted in an antibiotic prescription. Of the patients who received
an antibiotic, 90.9% rated their care as five stars whereas only 72.5% rated their care five stars
when not receiving a prescription, and there was a clear relationship between patient satisfaction
and an individual physician’s rate of prescribing antibiotic. [Fig. 1; 5]
The antibiotic resistance crisis cannot be solved through new antibiotics, as antibiotic
development has slowed with most new drugs simply consisting of minor variations over old
medications [6]. Barring development of an evolution-proof miracle drug, it does not seem
antibiotic development will be a long-lasting solution to combat resistance. Instead, there exists
an arms race between novel antibiotics and resistance mechanisms. For example, in the early
1980s many β-lactam antibiotics had become less effective due to resistance such as β-lactamase
enzymes [7]. New extended-spectrum cephalosporins were released which were initially
effective, but quickly extended-spectrum β-lactamases appeared. By 2010, over 200 different
2

Fig.1: Prescription of antibiotics has a significant correlation to patient satisfaction
rating. Almost all physicians in the 90th percentile had a prescription rate greater than 75% [5].

3

extended-spectrum β-lactamase had been discovered [7]. There are more examples like this
where new, effective antibiotics have become ineffective because of the evolution of antibiotic
resistance in bacteria (Fig. 2; 1). Thus, it is apparent that a more permanent solution to treat
antibiotic resistance is required than simply developing novel antibiotics.

4

Fig. 2. Development of Antibiotic Resistance to New Antibiotics [1].
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DEVELOPMENT OF IMPROVED DIAGNOSTICS

One area that has room for improvement and may lead to permanently better treatment is
diagnostics. Better, more available diagnostics can lead to new treatment options. There are
many strains of multidrug-resistant bacteria that have a dangerous resistance to many antibiotics.
This potentially leads physicians to jump to last-resort antibiotics more often than necessary,
reducing their efficacy overtime. Furthermore, there are many cases where a particular antibiotic
or treatment would likely be effective, but this needs to be identified early on during diagnosis
and treatment.
For example, a case study in 2012 looked at a potential treatment for respiratory tract
infection by multidrug-resistant Acetinobacter baumannii [8]. It was found that inhaled colistin
methanesulfonate was effective against the infection and significantly reduced hospital stays and
enhanced patient recovery. However, colistin is a last-resort antibiotic, which should not be used
more than necessary as some resistant strains have been documented, and there is some evidence
of rare neuro and nephrotoxicity [9]. Thus, diagnostic methods are important to distinguish
between necessary and unnecessary use of antibiotics such as colistin.
The CDC states that, “Diagnostics can be just as critical for fighting infections as
antibiotics. These tools help human and animal healthcare providers identify infections as soon
as possible and guide selection of the best treatment option for their patient. In addition, they
help sound the alarm that alerts local infection control programs and health departments to
emerging threats.” [1]. The CDC cites further benefits to improved diagnostic testing such as
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improving accuracy and speed of diagnosis, improving appropriate antibiotic use, reducing
unnecessary antibiotic use, and assisting epidemiological measures. More development is
required to current technology because it is costly, time consuming, and does not detect
emerging resistance markers or rapidly discriminate bacterial/fungal infections from viral ones
[1].
The complexity and severity of antibiotic resistant forms appear in stark contrast to
current diagnostic tools. Diagnostic tests for antibiotic resistance or susceptibility testing are
seldom used clinically unless an infection is severe or not responding to treatment. When used,
the primary method by clinics is to determine antibiotic resistance is culturing on Kirby-Bauer
disk diffusion plates. This method has some major drawbacks. It takes up to two days to plate
and isolate bacteria, and then another several hours to determine resistance via culture with
antimicrobial agents [10]. During this time, patients will often already be prescribed an
antibiotic, potentially an inappropriate one that contributes to resistance and makes it less
effective for successive patients. Further, there is a tremendous amount of diversity among
bacteria. Some species grow slowly or have special growth requirements and will not grow
easily on the Mueller-Hinton agar used in Kirby-Bauer. In fact, it is estimated that only 2% of
bacteria species are actually culturable [11], although the percentage is noticeably higher for
pathogens. Additionally, there are several antibiotics such as vancomycin which are composed of
large molecules that diffuse slowly. This slow diffusion makes the distinction between resistance
and susceptibility a matter of millimeters which can be difficult to determine. Finally, in vitro
susceptibility does not always translate to in vivo efficacy. For example, Salmonella enterica
exhibits in vitro susceptibility to aminoglycosides. However, in an actual infection Salmonella
invades host cells, protecting it from aminoglycosides which have poor membrane permeability
7

[12]. A better diagnostic method is needed to combat antibiotic resistance and improve patient
outcomes. This diagnostic method must be sufficiently rapid, inexpensive, and must be capable
of assessing susceptibility to a wider range of pathogens and antibiotics.
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DIFFERENT APPROACHES TO DIAGNOSIS
Currently, there are several approaches from which one can attempt to create a diagnostic
method fitting these criteria. As Sandle writes, “The use of genotypic approaches for detection of
antimicrobial resistance genes has been promoted as a way to increase the rapidity and accuracy
of susceptibility testing. Methods that employ the use of comparative genomics, genetic probes,
microarrays, nucleic acid amplification techniques (such as polymerase chain reaction (PCR)),
and DNA sequencing are capable of increased sensitivity, specificity, and speed in the detection
of specific known resistance genes”[10]. Genotypic methods are now capable, especially with
the ever-growing databases that catalogue research on genes denoting antibiotic resistance. For
example, one of the largest and most maintained databases is the Comprehensive Antibiotic
Resistance Database (CARD) that contains the sequences of 88 pathogens, 9560 chromosomes,
and 21362 plasmids, as well as other data [13].
For any potential genotypic method to detect antibiotic sensitivity, the first step of the
diagnostic procedure regardless is to collect a sample from the patient. This can take many forms
such as a throat swab, stool sample, blood sample, etc. This sample must be processed to remove
as much human DNA as possible, as there is often a low ratio of pathogen to human DNA.
Successful processing thus confers several advantages such as the ability to detect pathogens that
would be undetectable in unprocessed samples [14].
Various methods can be used to separate pathogen DNA from human genetic material.
The easiest ways often involve taking advantage of the size difference between eukaryotic cells
and pathogen cells or viruses. One method is to filter a sample through a filter. This allows for
9

bacteria cells and viruses to pass through, while larger human cells remain behind. To illustrate
with an example, consider a patient with a bloodstream infection. Most nucleated human blood
cells range in diameter from around 10 to 20 microns [15]. In contrast, most bacteria range from
0.2 to 2 microns in diameter, and of course, viruses are much smaller. Thus, we speculate that a
Millipore filter with a pore size around 10 microns should selectively filter pathogens from
human cells. Then, DNA extraction can be performed on the filtrate.
Another method to selectively obtain the cells of a pathogen is separation by
centrifugation. Differential centrifugation centrifuges a sample in a sucrose solution, with the
rate of sedimentation almost entirely dependent on the size of particles. However, this method
can have poor resolution as smaller particles near the bottom of the tube will pellet with larger
particles. Furthermore, particles along the sides of the tube will move more rapidly than in the
center [16]. Density gradient centrifugation solves some of these problems by using multiple
layers of increasing sucrose concentrations to give a much higher resolution than simple
differential centrifugation. Density gradient centrifugation offers two potential separation
methods, rate separation and equilibrium separation. Rate separation slowly centrifuges the
solution for a short time, so that larger particles travel farther than small ones. Equilibrium
separation centrifuges the solution rapidly for a longer time. This causes particles to separate out
by density rather than size. Centrifugation methods are easy and inexpensive to perform but may
be difficult to efficiently isolate pathogens from human cells, especially if the pathogen size or
density is unknown. Pathogens will vary greatly in size and density depending on species and,
depending on the type of clinical sample, there can be similar variation in human cells. Thus,
centrifugation appears to be much less of a one-size-fits-all method for separation than Millipore
filtration.
10

Hasan, et al. (2016) assessed the effectiveness of other methods in processing of samples.
They compared several detergents for the ability to selectively lyse human cells in spiked
cerebrospinal fluid (CSF) and nasopharyngeal aspirate (NPA) aliquots as compared to the
commercially available MolYsis kit (Molzym GmbH & Co. KG, D-28359, Bremen, Germany)
which was found to be ineffective [17]. The detergent with the most success was Saponin, a
glycoside with hemolytic activity. Saponin interacts with membrane-bound sterols, increasing
plasma membrane permeability and destroying the cell [17]. At a concentration of 0.025%,
Saponin was effective at enriching the concentration of microbial DNA (Fig. 3; 15). However, it
appears less effective on Gram-positive bacteria such as Streptococcus pneumoniae and
enveloped viruses such as HSVII
The procedure used in this study was simple and inexpensive. Saponin was added to
aliquots to a 0.025% concentration. Samples were then vortexed for 10 seconds and incubated
for 5 minutes at room temperature. DNAse was then added and the samples were incubated at
37℃ for 30 minutes. This represents yet another option for the selective enrichment of microbial
DNA.
After selective isolation of microbial cells, DNA is extracted. It is not uncommon for
procedures to involve enzymes, hazardous chemicals, fume hoods, and require a lot of time with
many steps involved. However, in a clinical setting, it is important to have an easy and rapid
extraction method. Recently, researchers have been looking into using hydrophilic ionic liquids.
These are organic salts which are liquid below 100℃ and are effective at lysing cells. In the past,
these liquids have had trouble with the hard peptidoglycan layer of Gram-positive bacteria, but a
recent paper shows a procedure that seems to overcome this difficulty [18]. That study compared
a simple procedure with ionic liquids to commercial DNA extraction kits and a traditional phenol
11

Fig. 3. Effectiveness of microbial DNA extraction methods using various detergents and
concentrations are compared for their ability to selectively lyse human cells. Samples were
processed and then analyzed with real-time PCR to measure the amount of nucleic acids present
in the extract. These methods were compared for different pathogens [17].
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chloroform/enzyme procedure. The most effective ionic liquid procedure was found to be adding
either 90% w/w 1-Ethyl-3-methylimidazolium acetate or 50% w/w choline hexanoate in Tris pH
8 buffer to pelleted and resuspended cells, followed by incubation at 65℃ for 5 minutes to lyse
cells. The authors used qPCR to quantitatively compare five different methods of extraction (Fig.
4; 16).
The ionic liquid procedures were never the best method for any strain of bacteria, but one
or both liquids were always close to optimal (Fig. 4; 18). Considering the potential savings in
time and money that the ionic liquid procedures provide, they may well be suitable for a clinical
diagnostic test. However, a potential downside to using ionic liquids is that they can have an
inhibitory effect on the amplification reaction in PCR. This inhibition can be mitigated by
dilution, although dilution can reduce the sensitivity of the diagnostic test, so that other
approaches such as the use of a DNA-binding column or silica beads to isolate DNA are
recommended [18].
After DNA extraction, PCR may be performed as a diagnostic procedure for antibiotic
sensitivity. Multiplex PCR has been used to identify antibiotic resistance and has proven
effective [19-21]. Advantages of this approach include sensitivity, specificity, inexpensiveness,
and rapidity. It certainly represents an improvement over traditional Kirby-Bauer or other similar
phenotypic methods of testing antibiotic sensitivity and in clinical situations where it is
important to rapidly or precisely identify antibiotic sensitivity, PCR represents a convincing
alternative.
However, PCR has disadvantages in that a level of technical knowledge and experience is
required to optimize and perform the procedure. Furthermore, PCR requires a variety of different
13

Fig. 4. Five DNA extraction methods were used and analyzed with qPCR to
quantify the amount of nucleic acids extracted. These were compared across a range of
both gram-positive and gram-negative pathogenic bacteria. [C₂mim]OAc abbreviates the
ionic liquid 1-Ethyl-3-methylimidazolium acetate and [Cho]Hex is choline hexanoate.
[18].
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chemicals to be kept on-hand, most of which must be stored frozen and must be checked to
ensure they are always in stock. These concerns may present a logistical headache for smaller
clinics although it is possible to purchase pre-mixed PCR kits which would streamline the
diagnosis process for clinics. The amount of technical knowledge required could also be
mitigated through automation of the process. Ultimately, however, the greatest limitation to PCR
for susceptibility testing does not appear to have a remedy. PCR is inherently limited in its scope
of detection. As a general-purpose antibiotic susceptibility diagnostic, PCR does not have
enough breadth to identify the incredibly numerous resistance forms.
Another diagnostic method for antibiotic sensitivity is a microarray system. There are
several disadvantages to the microarray platform for such a diagnostic system. It can be
expensive, user unfriendly, time-consuming, and probes must be carefully designed [22]. Despite
the disadvantages, it offers a major advantage in that the scope of a microarray diagnostic is
huge. Commercially available high density microarray chips can be spotted with up to 80,000
probe sequences. This would allow for broad diagnostic capability for many antibiotic resistance
genes, limited most by the time required to design probes and the ability to mitigate the
disadvantages of the platform.
To illustrate the use of a microarray, consider the most widely used class of antibiotics, βlactams. β-lactams function by binding to and inactivating penicillin-binding proteins, enzymes
that are required for the construction and maintenance of the bacterial cell wall. There are four
ways that bacteria resist β-lactams. (1) They can produce β-lactamases, which are enzymes that
directly degrade the antibiotics. (2) Gram-negative bacteria can also have efflux pumps that keep
the antibiotics from reaching the cell wall. (3) Some bacteria have a horizontally transferred gene
for a penicillin-binding protein that has an active site that does not recognize β-lactams. (4) Some
15

Gram-negative bacteria have point or insertion mutations in genes encoding porin proteins in the
outer membrane, and the loss of these porins means antibiotics cannot access the cell wall.
However, research indicates that this last type of resistance is not significant enough to cause
resistance unless it is coupled with one of the other three mechanisms of resistance [7]. For those
three mechanisms (β-lactamases, penicillin binding proteins, and efflux proteins) there are many
gene sequences available in CARD. Thus, complementary probes to these sequences could be
designed, taking into account a small amount of non-complementary pairing to accommodate
genetic drift, particularly in third codon positions. While this approach could not be used to
detect single nucleotide mutations to porin genes, that would not matter because that mechanism
of resistance must be coupled with a resistance mechanism that could be detected. The large
scope of a microarray device means that these concepts could be applied to many other classes of
antibiotics simultaneously, and there are several areas in which the typical microarray procedure
could become easier to perform in a clinical setting.
In many microarray experiments, the next step after extraction of genetic material is PCR
amplification. PCR is performed to enhance the sensitivity of the microarray diagnostic by
amplifying DNA before microarray hybridization. In some cases, DNA is randomly amplified
while in other cases primers specific to resistance genes have been used [23-25]. However, in the
majority of clinical samples with a problematic infection, PCR amplification should not be
necessary. Microarrays, especially high-density ones, have an abundance of probes and can
detect small amounts of complementary genetic material. Studies suggest that the detection limit
of microarrays without amplification is close to that of real-time PCR [26]. While the addition of
amplification could increase the sensitivity 100- to 1000-fold, this is not likely to be relevant
enough to justify PCR and the associated drawbacks in a clinical setting. As discussed
16

previously, a diagnostic method for antibiotic resistance must be rapid, inexpensive, and easy to
use. A PCR amplification would involve additional time, cost, and expertise required. If
increased sensitivity is needed, it could occur through sample preparation involving as little
dilution as possible and procedures to remove human DNA contaminants.
PCR can also be used to label a sample, and labeling could present a challenge without
PCR. Biotin is often used to label DNA for microarray procedures, but is a time-consuming
process [27]. One option may be to label DNA retroactively after hybridization. After
hybridization and the subsequent washes, a pre-prepared protein that has already been labeled
outside of the clinic could be added. If this protein binds selectively to double-stranded DNA or
is large enough to be incapable of binding to the relatively short probe sequences, then PCR is
unnecessary for labeling.
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MICROARRAY PLATFORM INNOVATION
The microarray process of hybridization and subsequent washes can take time and
requires expertise. Automation could be used to enable individuals with less technical knowledge
to perform the process. Many diagnostic tests are a self-contained system, which enables their
ease of use. In this case, a single device could be designed that is capable of automating the
procedures necessary to run extracted microbial DNA from a clinical sample on a high density
microarray chip. The device should be small and house a central bay for insertion of a single or
small amount of glass microarray slides. Once the microarray chip is inserted, the device would
be activated to perform a standardized procedure for the antibiotic sensitivity test. This would
consist of hybridization, wash, and reading results subroutines. The device would be connected
to a computer where compatible software would analyze and interpret results.
Such a device would represent a significant improvement over previous equipment for
microarray procedures which are either large, expensive machines performing a singular
function, or less expensive machines that require manual operation. A microarray diagnostic
procedure using such existing equipment is not practical enough to achieve prevalence in clinical
use because of the expertise and expense necessary to conduct microarray procedures as they are
today. However, a smaller device capable of automating the process from hybridization through
data interpretation, would be much more palatable to clinics.
While there may be multiple ways to develop this automated device, we present an
alternate microarray system that we have designed to meet the goals of easier automation,
efficiency, and improved DNA hybridization to the complementary probes. Hybridization can be
done in as little as a single hour without amplification and detect as low as 2ng or 15.6fM of
18

DNA [26]. With better hybridization, this could be even more sensitive. Our alternate process
makes use of the physical advantage of different geometric shapes. In a regular microarray, a
flat, rectangular piece of glass (the microarray chip) must oscillate for hours. The flat glass
design for probes often complements an agitation apparatus shaped like a basket. Such a
configuration for agitating solutions across the microarray chip is somewhat bulky, which limits
the number of probes that can occupy a machine at one time. By changing the probe shape from
a flat plane to a ring, there is more opportunity to utilize the same amount of space more
efficiently. The result would be an increased number of microarray chips which can
simultaneously occupy a machine of similar size, thus allowing more clinical samples to be
processed at one time.
Instead of a flat sheet of glass or polymer, this novel type of “ring microarray” would be
manufactured by immobilizing probe sequences on a long, thin, flat polymer surface which is
then curved and fused to form a ring structure. A ring microarray takes advantage of many
physical benefits. The first part of the process is the hybridization of genetic material to probes
on the microarray surface. The ring microarray has an advantage in this process because of its
circular shape. Current microarray hybridization machines are expensive, in part, because they
must ensure that the hybridization buffer and genetic material are evenly spread across the flat
surface and encounters each probe while simultaneously incubating. This is difficult and leads to
long hybridization times otherwise hybridization efficiency is detrimentally affected. A thin, ring
microarray could just be rotated to achieve the same purpose of contacting every probe. This is
significantly easier to automate. The hollow center of the ring could be used to provide a heating
source and uniformly incubate the array. Furthermore, the genetic material is more likely to be in
close proximity to its complementary probe because the chip has much less width and the probe
19

will encounter sample genetic material every time the ring makes a full circle. This should
increase hybridization efficiency allowing for a more sensitive and rapid procedure (Fig. 5).
Following hybridization, the next process in a microarray procedure is to wash off noncomplementary genetic material so that the chip can be scanned for fluorescence to “read” it.
This is a sensitive procedure and requires other expensive automated equipment or an
experienced and talented person to perform. A ring system, however, could take advantage of
gravity in that the ring, in an upright position, will enable gravity to pull contents to the bottom
but genetic material hybridized to the immobilized probe sequences will travel to the top. Thus, a
minimal or even no wash procedure could suffice if the reading system was located at the top of
the ring. Only hybridized material would make it to the top of the ring and be scanned for
fluorescence. Thus, because of the shape and positioning of components, the entire procedure of
hybridization, washing, and reading could be automated through a simple, slow circular motion
of the ring. Such an automated system would have ease of use, and be much more tractable for a
small to medium sized clinic to operate than any current system.
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Fig. 5. The concept of a ring microarray. Green dots represent sample DNA and
arrows represent their movement. Red dots represent the complementary probe hybridized to the
microarray surface. As shown, the probability of sample DNA encountering its complementary
probe is much higher on a ring than the traditional square layout.
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CONCLUSION
The ongoing and growing problem of antibiotic resistance requires development of a
broad, sensitive antibiotic susceptibility test. Of the technology available today the microarray
procedure is the closest to achieving this. However, microarrays have inherent disadvantages of
time and expense. The time can be significantly reduced at each stage of operation through
careful selection of procedures such as hydrophilic ionic liquids for DNA extraction, avoidance
of biotin labeling and PCR, and rapid hybridization. Expense can be reduced through automation
and, significantly, more efficient design of the microarray platform. With more research and
development, microarrays can fulfill the ambitious vision of a rapid, comprehensive, and
genetic-based antibiotic susceptibility diagnostic for clinical use.
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